Cerebral vasoconstriction and stroke after use of serotonergic drugs.
about
Abrupt-onset severe headachesA systematic review of causes of sudden and severe headache (Thunderclap Headache): should lists be evidence based?Postpartum reversible cerebral vasoconstriction syndrome: review and analysis of the current data.Is vasospasm requisite for posterior leukoencephalopathy in patients with primary thunderclap headaches?Ischemic stroke followed by acute thrombocytopenia: a double iatrogenic whammy.Reversible cerebral vasoconstriction syndrome and nonaneurysmal subarachnoid hemorrhage.Autonomic dysfunction in reversible cerebral vasoconstriction syndromes.Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency.Systematic review of reversible cerebral vasoconstriction syndrome.Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases.A reversible cerebral vasoconstriction syndromeReversible cerebral vasoconstriction syndrome: case report.Effects of common medications on cerebral vasospasm after subarachnoid haemorrhage.Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo.Cerebrovascular accident following MDMA ingestion.Brief serotonin exposure initiates arteriolar inward remodeling processes in vivo that involve transglutaminase activation and actin cytoskeleton reorganization.Clinical spectrum of thunderclap headache.Acute neurological issues in pregnancy and the peripartum.The Need for a Rational Approach to Vasoconstrictive Syndromes: Transcranial Doppler and Calcium Channel Blockade in Reversible Cerebral Vasoconstriction Syndrome.Reversible cerebral vasoconstriction syndrome: a thunderclap headache-associated condition.Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review.Migraine and genetic and acquired vasculopathies.Dramatic intracerebral hemorrhagic presentations of reversible cerebral vasoconstriction syndrome: three cases and a literature review.Reversible cerebral vasospasm, multilobular intracerebral hemorrhages, and nonaneurysmal subarachnoid hemorrhage: review of possible interrelationships.Reversible cerebral vasoconstriction syndrome: current and future perspectives.Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome.Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis.Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients.SSRI/SNRI Use is Not Associated with Increased Risk of Delayed Cerebral Ischemia After aSAH.The Typical Thunderclap Headache of Reversible Cerebral Vasoconstriction Syndrome and its Various Triggers.Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache.Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies.Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome.Benign cerebral angiopathy; postpartum cerebral angiopathy: characteristics and treatment.Cortical subarachnoid hemorrhage associated with reversible cerebral vasoconstriction syndrome after elective triplet cesarean delivery.Catastrophic reversible cerebral vasoconstriction syndrome associated with serotonin syndrome.Long-term outcomes after reversible cerebral vasoconstriction syndrome.Escitalopram and ischemic stroke: cause or chance association?Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): are calcium channel inhibitors a potential treatment option?Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events.
P2860
Q24629595-C6D4C01D-5A62-4E70-AB52-3C1FC5E2D165Q26858984-D6DDA8A2-5099-42C5-A008-13B9EC9AD5D4Q30922149-CBA4C650-65A9-4577-AF7A-156769D69057Q31039494-CE32F1CE-CEA7-41CA-AF6F-ABAF09AC7A3BQ33385757-0656F633-D338-4BFA-8BAF-B1E9F5B563EDQ34045398-FE5DF47B-A656-4927-B2C9-5E8C8B39AAF0Q34255056-3789B0DA-3B9E-4C37-8634-67FC2C76F554Q34409485-906F6362-51C7-45F0-82A4-9496034EE231Q34489830-AC8C18A7-03E9-494F-AAF9-2F6934EB18C4Q34533458-0465DC43-1B7C-4AED-834A-3771B7B4E725Q36157536-2C407383-A03D-4F5B-A510-96B3653DB207Q36259788-8DEE91F1-B77D-497F-B0ED-D3B340238CD6Q36349732-3FC06909-B84F-49A5-966E-1C587BB286B7Q36368027-9DC12F7A-E268-4744-810C-FAC97ED6DC8BQ36548376-DDF93C9B-1203-493F-B1ED-BF1DFB340420Q36699644-36810CE0-B4FF-4D85-9BB9-175624D2688FQ36941899-DAF025AF-C09B-418A-B28E-EC4C42014193Q37052664-E538EF7C-822E-43DD-8327-E42ADE17B866Q37298433-63BE4A93-E745-4401-931F-597D0B1E622FQ37408400-C8190A96-B7AC-4A5B-A73E-A96EE8F43C5DQ37562798-19B522C7-7716-4212-9446-F7C27C88248BQ37581975-C0A9CFC8-859F-48BA-92A2-DDD4C4C69DBBQ37663426-B76359EE-4BCC-434F-900A-0F8F469DA9D0Q37738270-C2542826-E36D-4292-947C-6BEC6390BB9BQ37921763-BA5A3610-3A32-4FEA-ACCF-83EBD0FA78CBQ38116417-DEF0591E-FD64-4E40-90A9-D16547F475B3Q38183266-4329397C-C4B5-495A-A0AC-03D01882B26AQ38402064-8C917540-5DDC-415F-9FB1-F3C1D4E56D16Q38564609-55C545C7-AE3A-498D-9348-80CA9659C723Q38789242-89EA80C7-C5F7-495B-B36D-6DB7CC8FB1DCQ38789469-8BEF60E8-48B2-4705-9A6C-3DA89AF21525Q39077689-6D1E5BE9-F259-4F00-90C2-CD32C6F11361Q39111616-F62D4544-BE73-4B0F-B75E-6A72CB62ACF8Q39352143-0C431CED-BBA4-40FB-AF07-102131EA8DBFQ39974168-3AAA7286-ED89-4C88-AC19-F0993C9803E6Q40235816-3765F27A-4EF9-4604-A88A-649C7526DE25Q41658607-ACEAD6DC-ABC9-4B69-B4CA-934D40B250DDQ42934825-E28CFAE1-7570-4E68-A207-52CAE92A968EQ44380442-B8913302-CCE2-472C-A1A6-D4BBC0D907BAQ44459623-C065DEBB-162B-4C2A-88EB-6AEEC470A7F2
P2860
Cerebral vasoconstriction and stroke after use of serotonergic drugs.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Cerebral vasoconstriction and stroke after use of serotonergic drugs.
@en
type
label
Cerebral vasoconstriction and stroke after use of serotonergic drugs.
@en
prefLabel
Cerebral vasoconstriction and stroke after use of serotonergic drugs.
@en
P2093
P356
P1433
P1476
Cerebral vasoconstriction and stroke after use of serotonergic drugs.
@en
P2093
Begleiter AF
Caviness VS
Koroshetz WJ
Singhal AB
P304
P356
10.1212/WNL.58.1.130
P407
P577
2002-01-01T00:00:00Z